Dario de Biase
Dario de Biase
Verified email at
Cited by
Cited by
Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas
FC Geyer, B Weigelt, R Natrajan, MBK Lambros, D de Biase, R Vatcheva, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010
Randomized trial of endobronchial ultrasound-guided transbronchial needle aspiration with and without rapid on-site evaluation for lung cancer genotyping
R Trisolini, A Cancellieri, C Tinelli, D de Biase, I Valentini, G Casadei, ...
Chest 148 (6), 1430-1437, 2015
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III
M Visani, D de Biase, G Marucci, S Cerasoli, E Nigrisoli, MLB Reggiani, ...
Molecular oncology 8 (2), 417-430, 2014
Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance
G Acquaviva, M Visani, A Repaci, KJ Rhoden, D de Biase, A Pession, ...
Histopathology 72 (1), 6-31, 2018
TERT Promoter Mutations in Papillary Thyroid Microcarcinomas
D de Biase, G Gandolfi, M Ragazzi, M Eszlinger, V Sancisi, M Gugnoni, ...
Thyroid 25 (9), 1013-1019, 2015
aPKCζ cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia
D Grifoni, F Garoia, P Bellosta, F Parisi, D De Biase, G Collina, D Strand, ...
Oncogene 26 (40), 5960-5965, 2007
Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review
S Fiorino, L Bacchi-Reggiani, D De Biase, A Fornelli, M Masetti, A Tura, ...
World journal of gastroenterology 21 (45), 12896, 2015
Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy)
D de Biase, M Visani, U Malapelle, F Simonato, V Cesari, C Bellevicine, ...
PloS one 8 (12), e83607, 2013
Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications
AA Brandes, E Franceschi, A Paccapelo, G Tallini, D De Biase, ...
The oncologist 22 (4), 432-437, 2017
Expression of p63 is the sole independent marker of aggressiveness in localised (stage I–II) Merkel cell carcinomas
S Asioli, A Righi, D De Biase, L Morandi, V Caliendo, F Picciotto, ...
Modern Pathology 24 (11), 1451-1461, 2011
Role of microRNAs in the main molecular pathways of hepatocellular carcinoma
F Vasuri, M Visani, G Acquaviva, T Brand, M Fiorentino, A Pession, ...
World journal of gastroenterology 24 (25), 2647, 2018
High-Sensitivity BRAF Mutation Analysis: BRAF V600E Is Acquired Early During Tumor Development but Is Heterogeneously Distributed in a Subset of Papillary …
D de Biase, V Cesari, M Visani, GP Casadei, N Cremonini, G Gandolfi, ...
The Journal of Clinical Endocrinology & Metabolism 99 (8), E1530-E1538, 2014
MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B-and C-related-hepatocellular-carcinoma
S Fiorino, ML Bacchi-Reggiani, M Visani, G Acquaviva, A Fornelli, ...
World journal of gastroenterology 22 (15), 3907, 2016
Indoleamine 2, 3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment
S Moretti, E Menicali, P Voce, S Morelli, S Cantarelli, M Sponziello, ...
The Journal of Clinical Endocrinology & Metabolism 99 (5), E832-E840, 2014
Next generation sequencing improves the accuracy of KRAS mutation analysis in endoscopic ultrasound fine needle aspiration pancreatic lesions
D de Biase, M Visani, P Baccarini, AM Polifemo, A Maimone, A Fornelli, ...
PloS one 9 (2), e87651, 2014
Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy
S Fiorino, C Gallo, M Zippi, S Sabbatani, R Manfredi, R Moretti, E Fogacci, ...
Aging clinical and experimental research 32, 2115-2131, 2020
What is new on ovarian carcinoma: integrated morphologic and molecular analysis following the new 2020 World Health Organization classification of female genital tumors
A De Leo, D Santini, C Ceccarelli, G Santandrea, A Palicelli, G Acquaviva, ...
Diagnostics 11 (4), 697, 2021
454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed …
A Altimari, D de Biase, G De Maglio, E Gruppioni, E Capizzi, ...
OncoTargets and therapy, 1057-1064, 2013
Allele Specific Locked Nucleic Acid Quantitative PCR (ASLNAqPCR): An Accurate and Cost-Effective Assay to Diagnose and Quantify KRAS and BRAF Mutation
L Morandi, D de Biase, M Visani, V Cesari, G De Maglio, S Pizzolitto, ...
PloS one 7 (4), e36084, 2012
Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis
S Piana, M Ragazzi, G Tallini, D de Biase, A Ciarrocchi, A Frasoldati, ...
Human pathology 44 (4), 556-565, 2013
The system can't perform the operation now. Try again later.
Articles 1–20